Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3060]

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale...

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus ( Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini )

Optimising multiple myeloma care in Latin America

Dr David Gómez-Almaguer - Autonomous University of Nuevo León, Monterrey, Mexico

Optimising multiple myeloma care in Latin America ( Dr David Gómez-Almaguer - Autonomous University of Nuevo León, Monterrey, Mexico )

Global trends and inequalities in breast cancer survival and care

Prof Claudia Allemani, Dr Ophira Ginsburg, Prof Vesna Zadnik

Global trends and inequalities in breast cancer survival and care ( Prof Claudia Allemani, Dr Ophira Ginsburg, Prof Vesna Zadnik )

Multiple myeloma in a resource constrained setting

Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda

Multiple myeloma in a resource constrained setting ( Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda )

ASCO GU 2024: Current best practice for mRCC

Prof Jens Bedke, Prof Thomas Powles, Prof Michael Staehler and Dr Wenxin Xu

ASCO GU 2024: Current best practice for mRCC ( Prof Jens Bedke, Prof Thomas Powles, Prof Michael Staehler and Dr Wenxin Xu )

ASCO GU 2024: Latest in PARP inhibitors for prostate cancer

Dr Friederike Schlurmann, Dr Nabil Adra, Dr Emmanuel Antonarakis and Dr Hiroshi...

ASCO GU 2024: Latest in PARP inhibitors for prostate cancer ( Dr Friederike Schlurmann, Dr Nabil Adra, Dr Emmanuel Antonarakis and Dr Hiroshi Kitamura )

Updates on lung cancer from WCLC and ESMO 2023

Dr Luis Raez - Memorial Cancer Institute, Miami, USA

Updates on lung cancer from WCLC and ESMO 2023 ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )

Subcutaneous delivery of nivolumab is effective in treating metastatic ccRCC

Dr Saby George - Roswell Park Comprehensive Cancer Center, New York, USA

Subcutaneous delivery of nivolumab is effective in treating metastatic ccRCC ( Dr Saby George - Roswell Park Comprehensive Cancer Center, New York, USA )

Enfortumab vedotin in combination with pembrolizumab is a potential new...

Dr Michiel Simon Van Der Heijden - Netherlands Cancer Institute, Amsterdam...

Enfortumab vedotin in combination with pembrolizumab is a potential new standard of care for 1L la/mUC ( Dr Michiel Simon Van Der Heijden - Netherlands Cancer Institute, Amsterdam, Netherlands )

Enzalutamide monotherapy prolongs MFS compared to leuprolide alone in men with...

Dr Neal Shore - Carolina Urologic Research Center, Myrtle Beach, USA

Enzalutamide monotherapy prolongs MFS compared to leuprolide alone in men with high-risk biochemically recurrent PC ( Dr Neal Shore - Carolina Urologic Research Center, Myrtle Beach, USA )

Combination of cabozantinib and atezolizumab shows moderate activity in...

Dr Enrique Grande - MD Anderson Cancer Center Madrid, Madrid, Spain

Combination of cabozantinib and atezolizumab shows moderate activity in treating metastatic adrenocortical carcinoma ( Dr Enrique Grande - MD Anderson Cancer Center Madrid, Madrid, Spain )

Novel therapies and combinations in ovarian cancer

Dr Alexandria Leary - Institute Gustave Roussy, Villejuif, France

Novel therapies and combinations in ovarian cancer ( Dr Alexandria Leary - Institute Gustave Roussy, Villejuif, France )

More from ecancer